Halozyme has separately combined recombinant human hyaluronidase – an enzyme found to have properties helpful to the administration of drugs in patients – with two existing medicinal products: ...
The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...
Despite the impact of the pandemic on cancer care, Perjeta grew 17% to CHF 2.9 billion ($3.2 billion) in the first nine months of 2020, now just fractionally behind Herceptin which declined 31% to ...
Treatment for HER2-positive breast cancer depends on tumor size and spread but may involve a combination of chemotherapy, targeted therapy, monoclonal antibody therapy, and kinase inhibitors. HER2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback